Latest News
BiBBInstruments reports additional US orders during targeted EndoDrill GI launch
17 December 2025 - Swedish cancer diagnostics company BiBBInstruments AB (Spotlight: BIBB) said on Wednesday that it received additional fourth-quarter orders from its US distributor TaeWoong Medical USA worth USD31,840 (SEK 300k).The orders form par...
GENinCode expands Mexico presence with CARDIO inCode-Score distribution agreement
17 December 2025 - Oxford based predictive genetics company GENinCode Plc (AIM: GENI) revealed on Wednesday that it has entered into a commercial distribution agreement with Sohin Genetics to market CARDIO inCode-Score in Mexico, extending access to ...
Avacta reports tumour shrinkage and 90% disease control rate for AVA6000 in salivary gland cancer patients
17 December 2025 - Biopharmaceutical company Avacta Therapeutics (AIM: AVCT) on Wednesday reported positive preliminary Phase 1b data for faridoxorubicin (AVA6000) in patients with salivary gland cancer, showing clinically meaningful tumour shrinkage...
Galderma reports data showing rapid itch and sleep improvement with nemolizumab in dermatitis conditions
17 December 2025 - Dermatology specialist Galderma (SWX:GALD) on Wednesday reported new clinical data showing that Nemluvio (nemolizumab) can deliver rapid relief of itch and sleep disturbance as early as 48 hours in patients with moderate-to-severe ...
Sanofi's efdoralprin alfa receives EU orphan designation for AATD-related emphysema
17 December 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced late Tuesday that the European Medicines Agency has granted orphan designation to efdoralprin alfa (SAR447537, formerly known as INBRX-101) for the p...